Strategies Needed to Improve Delivery of Alzheimer Disease-Modifying Therapies
TUESDAY, Jan. 30, 2024 (HealthDay News) — Strategies are needed to improve the delivery of...
Read More
Search Physician’s Weekly
Search for articles, editorials, meeting coverage, podcasts, and more
Showing 1 - 20 of 207 results for 'disease-modifying therapies'
Use of multiple sclerosis disease-modifying therapies during pregnancy in France: Nationwide study between 2010 and 2021.
Multiple sclerosis (MS) frequently affects women of childbearing age and pregnant women.To assess the use of MS disease-modifying therapies (DMTs) during pregnancy in France over the last decade, marked by an increasing DMTs...
Read More
Disease-modifying therapies do not affect sleep quality or daytime sleepiness in a large Australian MS cohort.
Poor sleep is common in multiple sclerosis (MS) and may impact daily functioning. The extent to...
Read More
Effects of disease-modifying therapies on lipid parameters in patients with multiple sclerosis.
Cholesterol and lipids are essential components of nerve cells. Myelin synthesis and stabilization...
Read MoreAdherence and persistence to self-administered disease-modifying therapies in patients with multiple sclerosis: A multisite analysis.
Though there are several disease-modifying therapy (DMT) options for patients with multiple sclerosis (MS), treatment outcomes rely on patient adherence and persistence. Previous studies have demonstrated suboptimal adherence...
Read More
An Observational Study of Multiple Sclerosis Patients Treated with Ocrelizumab and Other Disease-Modifying Therapies on Cellular & Humoral Immune Responses to SARS-CoV-2 Infection
For a study, researchers sought to assess the effect of disease-modifying treatments (DMTs) for...
Read More
Use of Disease-Modifying Therapies by Women With MS
Women of reproductive age were more likely to be diagnosed with multiple sclerosis (MS). Although...
Read More
Changes in Blood Pressure are Linked to the Start of Disease-Modifying Therapies in Rheumatoid Arthritis
For a study, researchers examined the effects of disease-modifying medications for rheumatoid...
Read More
Humoral immune response in convalescent COVID-19 people with multiple sclerosis treated with high-efficacy disease-modifying therapies: A multicenter, case-control study.
To determine the influence of high-efficacy disease modifying therapy (DMT) on the development of...
Read MoreAdvertisement
Association between multiple sclerosis disease severity and adherence to disease-modifying therapies.
For multiple sclerosis (MS) patients taking disease-modifying therapies (DMTs), adherence to...
Read MoreMS disease-modifying therapies influence COVID-19 infection severity
MS patients treated with anti-CD20 therapies ocrelizumab and rituximab have an increased risk of severe COVID-19 infection, whereas treatment with interferon or teriflunomide could reduce that risk. These were the preliminary...
Read More
Multiple sclerosis hospitalizations among users of oral disease-modifying therapies.
Oral disease-modifying therapies, namely dimethyl fumarate, fingolimod and teriflunomide, have...
Read More
COVID-19 in Patients with Multiple Sclerosis: Associations with Disease-Modifying Therapies.
Disease-modifying therapies (DMTs) for multiple sclerosis (MS) target immunity and have the...
Read More
The risk of infection in patients with multiple sclerosis treated with disease-modifying therapies: A Delphi consensus statement.
The risk of infection associated with immunomodulatory or immunosuppressive disease-modifying...
Read More
ACTRIMS-ECTRIMS: Progressive Forms of MS and Disease-Modifying Therapies
Health Union has been accepted to present research, in the form of two poster presentations,...
Read More
Immune modulation via T regulatory cell enhancement: disease-modifying therapies for autoimmunity and their potential for chronic allergic and inflammatory diseases – An EAACI position paper of the Task Force on Immunopharmacology (TIPCO).
Therapeutic advances using targeted biologicals and small molecule drugs have achieved significant...
Read More
SMA: Disease-Modifying Therapies Change the Course of Patients’ Lives
Two drugs now approved in the U.S., and a third is under review New treatments for 5q spinal...
Read More
Real-World Comparative Effectiveness of Advanced Therapies in Psoriatic Arthritis
PRO-SPIRIT study examines the real-world efficacy results of disease-modifying antirheumatic drugs for patients with psoriatic arthritis.
Read More
Q&A: Examining Emerging Therapies to Restore Function in CNS Diseases in MS
More targeted, higher efficacious medications can drastically reduce the risk for accruing disability in newly diagnosed patients with MS.
Read More
2001 to 2020 Saw Shift in Rx for Disease-Modifying Therapy for Multiple Sclerosis
THURSDAY, July 27, 2023 (HealthDay News) — Oral disease-modifying therapies (DMTs)...
Read More